Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rick Greupink

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 28, 2011
Interaction of fluvastatin with the liver-specific Na+ -dependent taurocholate cotransporting polypeptide (NTCP)Rick Greupink, Lieve Dillen, Mario Monshouwer, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 29, 2013
Semi-mechanistic physiologically-based pharmacokinetic modeling of clinical glibenclamide pharmacokinetics and drug-drug-interactionsRick Greupink, Marieke Schreurs, Marina S Benne, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 17, 2020
[Black particles in plasma and carcinogenic pills]C Kees Kramers, J C A Hans Smit, Rick Greupink, et al.
AIDS (London, England)|February 26, 2016
First reported use of elvitegravir and cobicistat during pregnancyStein Schalkwijk, Angela Colbers, Deborah Konopnicki, et al.
Clinical Pharmacokinetics|February 16, 2024
Towards More Robust Evaluation of the Predictive Performance of Physiologically Based Pharmacokinetic Models: Using Confidence Intervals to Support Use of Model-Informed Dosing in Clinical CareMarjolein D van Borselen, Laurens Auke Æmiel Sluijterman, Rick Greupink, et al.
AIDS (London, England)|December 20, 2023
The impact of obesity on doravirine exposure in people with HIVLeena Zino, Lianne P M van Bussel, Rick Greupink, et al.
Drug Delivery and Translational Research|October 14, 2024
Targeted lipid nanoparticles to prevent trans-placental passage in the ex vivo human placental cotyledon perfusion modelCaren van Kammen, Hedwig van Hove, Dimitrios Kapsokalyvas, et al.
Pharmaceutical Research|July 20, 2006
Mannose-6-phosphate/insulin-Like growth factor-II receptors may represent a target for the selective delivery of mycophenolic acid to fibrogenic cellsRick Greupink, Hester I Bakker, Harry van Goor, et al.
Current Research in Toxicology|January 31, 2024
Placental transfer of tofacitinib in the <i>ex vivo</i> dual-side human placenta perfusion modelGaby A M Eliesen, Milou Fransen, Hedwig van Hove, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 30, 2012
In silico identification of potential cholestasis-inducing agents via modeling of Na(+)-dependent taurocholate cotransporting polypeptide substrate specificityRick Greupink, Sander B Nabuurs, Barbara Zarzycka, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 28, 2011
Interaction of fluvastatin with the liver-specific Na+ -dependent taurocholate cotransporting polypeptide (NTCP)Rick Greupink, Lieve Dillen, Mario Monshouwer, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 29, 2013
Semi-mechanistic physiologically-based pharmacokinetic modeling of clinical glibenclamide pharmacokinetics and drug-drug-interactionsRick Greupink, Marieke Schreurs, Marina S Benne, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 17, 2020
[Black particles in plasma and carcinogenic pills]C Kees Kramers, J C A Hans Smit, Rick Greupink, et al.
AIDS (London, England)|February 26, 2016
First reported use of elvitegravir and cobicistat during pregnancyStein Schalkwijk, Angela Colbers, Deborah Konopnicki, et al.
Clinical Pharmacokinetics|February 16, 2024
Towards More Robust Evaluation of the Predictive Performance of Physiologically Based Pharmacokinetic Models: Using Confidence Intervals to Support Use of Model-Informed Dosing in Clinical CareMarjolein D van Borselen, Laurens Auke Æmiel Sluijterman, Rick Greupink, et al.
AIDS (London, England)|December 20, 2023
The impact of obesity on doravirine exposure in people with HIVLeena Zino, Lianne P M van Bussel, Rick Greupink, et al.
Drug Delivery and Translational Research|October 14, 2024
Targeted lipid nanoparticles to prevent trans-placental passage in the ex vivo human placental cotyledon perfusion modelCaren van Kammen, Hedwig van Hove, Dimitrios Kapsokalyvas, et al.
Pharmaceutical Research|July 20, 2006
Mannose-6-phosphate/insulin-Like growth factor-II receptors may represent a target for the selective delivery of mycophenolic acid to fibrogenic cellsRick Greupink, Hester I Bakker, Harry van Goor, et al.
Current Research in Toxicology|January 31, 2024
Placental transfer of tofacitinib in the <i>ex vivo</i> dual-side human placenta perfusion modelGaby A M Eliesen, Milou Fransen, Hedwig van Hove, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 30, 2012
In silico identification of potential cholestasis-inducing agents via modeling of Na(+)-dependent taurocholate cotransporting polypeptide substrate specificityRick Greupink, Sander B Nabuurs, Barbara Zarzycka, et al.
Pageof 8